GILEAD SCIENCES, INC. (GILD) Cash flow
Market cap
$172B
P/E ratio
20.4x
| 2010/12 | 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Stock-based compensation | 200 | 192 | 209 | 252 | 360 | 382 | 380 | 638 | 845 | 636 | 643 | 635 | 637 | 766 | 835 | 894 |
| Cash from operations | 2,834 | 3,639 | 3,195 | 3,105 | 12,818 | 20,329 | 16,669 | 11,898 | 8,400 | 9,144 | 8,168 | 11,384 | 9,072 | 8,006 | 10,828 | 10,019 |
| Capital expenditures | -62 | -132 | -397 | -191 | -557 | -747 | -748 | -590 | -924 | -825 | -650 | -579 | -728 | -585 | -523 | -563 |
| Cash from investing | -1,938 | 3,590 | -11,846 | -254 | -1,823 | -12,475 | -11,985 | -16,069 | 14,355 | -7,817 | -14,615 | -3,131 | -2,466 | -2,265 | -3,449 | -4,793 |
| Payments for dividends | - | - | - | - | - | 1,874 | 2,455 | 2,731 | 2,971 | 3,222 | 3,449 | 3,605 | 3,709 | 3,809 | 3,918 | 4,003 |
| Repurchases of common stock | 4,023 | 2,383 | 667 | 582 | 5,349 | 10,002 | 11,001 | 954 | 2,900 | 1,749 | 1,583 | 546 | 1,396 | 1,000 | 1,150 | 1,922 |
| Repayments of term debt | - | 650 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cash from financing | -1,339 | 1,764 | 563 | -2,544 | -3,025 | -4,963 | -9,347 | 3,393 | -12,318 | -7,634 | 770 | -8,877 | -6,469 | -5,125 | -3,433 | -7,745 |
| Free cash flow | ||||||||||||||||
| FCF margin (%) |